Nantahala Capital Management, LLC Keros Therapeutics, Inc. Put Options Transaction History
Nantahala Capital Management, LLC
- $1.99 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KROS
# of Institutions
172Shares Held
29.9MCall Options Held
341KPut Options Held
102K-
Black Rock Inc. New York, NY2.51MShares$25.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$20.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.89MShares$19.6 Million1.68% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$17.4 Million2.53% of portfolio
-
State Street Corp Boston, MA1.2MShares$12.4 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $266M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...